National Institute of Allergy and Infectious Diseases

Activity by year

20162017201820192020202120222023202420252026

Contract

Dec 27, 2016CONTRACTUnited States$159.0M
CSRA's DynPort Vaccine Company wins $159M NIAID contract
CSRA Inc.'s subsidiary DynPort Vaccine Company LLC received a multiple-award IDIQ contract valued up to $159 million from the National Institute of Allergy and Infectious Diseases to manage medical product development initiatives.
CSRA DynPort Vaccine Company National Institute of Allergy and Infectious Diseases customer #Medical Devices prnewswire.com

Suppliers

Loading…